Home - Products - GPCR/G Protein - Adrenergic Receptor - Soquinolol

Soquinolol

CAS No. 61563-18-6

Soquinolol( —— )

Catalog No. M34427 CAS No. 61563-18-6

Soquinolol (Soquinolol mucate) is a beta-adrenergic receptor antagonist with weak local anesthetic activity.Soquinolol has good enteral efficacy and a long duration of action.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	200	In Stock
10MG	302	In Stock
25MG	489	In Stock
50MG	695	In Stock
100MG	977	In Stock
200MG	1321	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Soquinolol
Note

Research use only, not for human use.
Brief Description

Soquinolol (Soquinolol mucate) is a beta-adrenergic receptor antagonist with weak local anesthetic activity.Soquinolol has good enteral efficacy and a long duration of action.
Description

Soquinolol (Soquinolol mucate) is a beta-adrenergic receptor antagonist with weak local anesthetic activity.Soquinolol has good enteral efficacy and a long duration of action.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

Adrenergic Receptor
Recptor

Adrenergic Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

61563-18-6
Formula Weight

306.4
Molecular Formula

C17H26N2O3
Purity

>98% (HPLC)
Solubility

——
SMILES

O(CC(CNC(C)(C)C)O)C1=C2C(CN(C=O)CC2)=CC=C1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Butofilolol

Butofilolol is a novel beta-blocker with antihypertensive activity and can be used to study hypertension.
OPC-28326

OPC-28326 is a specific an α2-adrenergic receptor antagonist and acts as a peripheral vasodilator. OPC-28326 inhibits α2A-, α2B- and α2C-adrenoceptors with Ki of 2040, 285, and 55?nM, respectively.
Alfuzosin

Alfuzosin (SL 77499) is an orally available, competitive α1-adrenoceptor antagonist.Alfuzosin induces smooth muscle relaxation in the bladder neck and prostate.

Sign In Join Free